Stock listing

OTC:AAVXF Abivax SA Stock

US listing (OTC) of Abivax SA · home listing Euronext:ABVX

Follow Abivax SA into a list and get an email when it puts out news.

Share price · OTC:AAVXF

$84.80 USD 0.00 (0.0%)

Close on Nov 6, 2026

Past year -17.6% · daily closes, Nov 6, 2025 – Nov 6, 2026, adjusted for splits
Day range
$84.80 – $84.80 USDNov 6, 2026
Market cap
$7.40B USDAt the close on Nov 6, 2026 · price × 87.27M shares outstanding
52-week range
$71.26 – $139.00 USDLowest and highest trades, Nov 7, 2025 – Nov 6, 2026
Traded on an average day
$6,447 USDMedian day 0 shares · 59 days with no trades · last 3 months, Aug 6, 2026 – Nov 6, 2026
Abivax SA logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
Euronext:ABVX · Home€75.50 EUR-1.40 (-1.8%)128,059€75.20€76.15€74.25€76.90Close on Nov 17, 2026
NASDAQ:ABVX$82.10 USD-1.51 (-1.8%)1,372,710$82.86$84.31$81.83$83.61Close on Nov 17, 2026
LSE:0RA9€75.15 EUR-1.75 (-2.3%)2,062€76.00€76.00€74.60€76.90Close on Nov 17, 2026
OTC:AAVXF$84.80 USD0.00 (0.0%)—$84.80$84.80$84.80$84.80Close on Nov 6, 2026
Frankfurt:2X1€77.00 EUR+1.15 (+1.5%)101€74.65€77.00€74.65€75.85Close on Nov 17, 2026
Frankfurt:2X10€74.00 EUR-3.50 (-4.5%)40€74.00€74.00€74.00€77.50Close on Nov 17, 2026

Daily closes

Last 3 months, Aug 6, 2026 – Nov 6, 2026 · OTC:AAVXF · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$84.800.000.0%$84.80$84.80$84.800
$84.80-54.20-39.0%$84.80$84.80$84.80100
$139.000.000.0%$139.00$139.00$139.000
$139.000.000.0%$139.00$139.00$139.000
$139.000.000.0%$139.00$139.00$139.000
$139.000.000.0%$139.00$139.00$139.000
$139.000.000.0%$139.00$139.00$139.000
$139.000.000.0%$139.00$139.00$139.000
$139.000.000.0%$139.00$139.00$139.000
$139.000.000.0%$139.00$139.00$139.000
$139.000.000.0%$139.00$139.00$139.000
$139.000.000.0%$139.00$139.00$139.000
$139.000.000.0%$139.00$139.00$139.000
$139.000.000.0%$139.00$139.00$139.000
$139.000.000.0%$139.00$139.00$139.000
$139.000.000.0%$139.00$139.00$139.000
$139.000.000.0%$139.00$139.00$139.000
$139.000.000.0%$139.00$139.00$139.000
$139.000.000.0%$139.00$139.00$139.000
$139.000.000.0%$139.00$139.00$139.000
$139.000.000.0%$139.00$139.00$139.000
$139.000.000.0%$139.00$139.00$139.000
$139.000.000.0%$139.00$139.00$139.000
$139.000.000.0%$139.00$139.00$139.000
$139.000.000.0%$139.00$139.00$139.000
$139.000.000.0%$139.00$139.00$139.000
$139.000.000.0%$139.00$139.00$139.000
$139.000.000.0%$139.00$139.00$139.000
$139.000.000.0%$139.00$139.00$139.000
$139.000.000.0%$139.00$139.00$139.000
$139.000.000.0%$139.00$139.00$139.000
$139.000.000.0%$139.00$139.00$139.000
$139.000.000.0%$139.00$139.00$139.000
$139.000.000.0%$139.00$139.00$139.000
$139.000.000.0%$139.00$139.00$139.000
$139.000.000.0%$139.00$139.00$139.000
$139.000.000.0%$139.00$139.00$139.00500
$139.000.000.0%$139.00$139.00$139.00500
$139.000.000.0%$139.00$139.00$139.00500
$139.000.000.0%$139.00$139.00$139.000
$139.000.000.0%$139.00$139.00$139.000
$139.000.000.0%$139.00$139.00$139.000
$139.000.000.0%$139.00$139.00$139.000
$139.000.000.0%$139.00$139.00$139.000
$139.000.000.0%$139.00$139.00$139.000
$139.000.000.0%$139.00$139.00$139.00500
$139.000.000.0%$139.00$139.00$139.000
$139.000.000.0%$139.00$139.00$139.000
$139.000.000.0%$139.00$139.00$139.000
$139.000.000.0%$139.00$139.00$139.00500
$139.000.000.0%$139.00$139.00$139.000
$139.000.000.0%$139.00$139.00$139.000
$139.000.000.0%$139.00$139.00$139.000
$139.000.000.0%$139.00$139.00$139.000
$139.000.000.0%$139.00$139.00$139.000
$139.000.000.0%$139.00$139.00$139.000
$139.000.000.0%$139.00$139.00$139.000
$139.000.000.0%$139.00$139.00$139.000
$139.000.000.0%$139.00$139.00$139.00500
$139.000.000.0%$139.00$139.00$139.000
$139.000.000.0%$139.00$139.00$139.000
$139.000.000.0%$139.00$139.00$139.000
$139.000.000.0%$139.00$139.00$139.000
$139.000.000.0%$139.00$139.00$139.000
$139.000.000.0%$139.00$139.00$139.000
$139.000.000.0%$139.00$139.00$139.000
Ticker
OTC:AAVXF
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
OTC
Currency
USD

What changed lately

Calls

Replays

  • Abivax (Euronext:ABVX) Q4 2023 Earnings Call

    Mon, Apr 08, 2024 · 8:30 AM ET

    Watch Transcript

Latest news

All Abivax SA news

Financings

  • Public offering of american Depositary Shares

    Jul 6, 2026

    Closed: US$920M raised · Leerink Partners +5

    Dealers: Leerink Partners (co-lead), Morgan Stanley (co-lead), Piper Sandler (co-lead), Guggenheim Securities (co-lead), LifeSci Capital, Van Lanschot Kempen

    Use of proceeds: Together with existing cash, to finance operations into the fourth quarter of 2029

    Closed Jul 6, 2026

  • Public offering of american Depositary Shares

    Jul 2, 2026

    Made bigger: about US$920M · US$125 a share · Leerink Partners +5

    Dealers: Leerink Partners (co-lead), Morgan Stanley & Co. LLC (co-lead), Piper Sandler & Co. (co-lead), Guggenheim Securities, LLC (co-lead), LifeSci Capital, Van Lanschot Kempen

    Use of proceeds: Potential US commercialization of obefazimod, clinical R&D mainly in ulcerative colitis and Crohn's disease, and general corporate purposes

    Announced Jun 30, 2026 · Made bigger Jul 1, 2026 · Made bigger Jul 2, 2026

  • Public offering of american Depositary Shares

    Jul 28, 2025

    Closed: US$747.5M raised · US$64 a share · Leerink Partners +5

    Dealers: Leerink Partners (co-lead), Piper Sandler & Co. (co-lead), Guggenheim Securities, LLC (co-lead), LifeSci Capital, BTIG, Van Lanschot Kempen

    Use of proceeds: Finance operations into the fourth quarter of 2027, giving 12 months of cash runway after the planned NDA submission for Ulcerative Colitis

    Announced Jul 23, 2025 · Update Jul 24, 2025 · Made bigger Jul 25, 2025 · Closed Jul 28, 2025

Read by 6ix AI from the company's releases

Decks

Abivax SA on 6ix

Sector
Health care
Industry
Biotechnology
News releases
30 in the last 12 months · 49 in all · newest Nov 2, 2026 · oldest 2025
Calls
1 call with a replay · 1 with a transcript · latest Apr 8, 2024
Decks
39 decks · latest July 2026

Where Abivax SA is listed

ListingExchangeCountryCurrency
Euronext:ABVX · Home listingEuronextFranceEUR
NASDAQ:ABVXNASDAQUnited StatesUSD
LS Exchange:A14UQCLS ExchangeGermanyEUR
gettex:2X1gettexGermanyEUR
LSE:0RA9LSEUnited KingdomEUR
Xetra:2X1XetraGermanyEUR
Tradegate:2X1TradegateGermanyEUR
OTC:AAVXF · This pageOTCUnited StatesUSD
Lang & Schwarz:A14UQCLang & SchwarzGermanyEUR
Aquis:ABVXPAquisUnited KingdomEUR
Frankfurt:2X1FrankfurtGermanyEUR
gettex:2X10gettexGermanyEUR
BX Swiss:ABVXBX SwissSwitzerlandCHF
Dusseldorf:2X1DusseldorfGermanyEUR
Lang & Schwarz:A3EWCPLang & SchwarzGermanyEUR
Munich:2X1MunichGermanyEUR
Hamburg:2X1HamburgGermanyEUR
Aquis:ABVXPAquisUnited KingdomEUR
BOATS:ABVXBOATSUnited StatesUSD
Frankfurt:2X10FrankfurtGermanyEUR
LS Exchange:A3EWCPLS ExchangeGermanyEUR
Stuttgart:2X1StuttgartGermanyEUR
Turquoise:ABVXPTurquoiseUnited KingdomEUR
VIE:ABVXViennaAustriaEUR
Dusseldorf:2X10DusseldorfGermanyEUR
Hamburg:2X10HamburgGermanyEUR
Munich:2X10MunichGermanyEUR
Stuttgart:2X10StuttgartGermanyEUR
Tradegate:2X10TradegateGermanyEUR
Hanover:2X1HanoverGermanyEUR

Log in to ask 6ix AI your own questions about Abivax SA.